SmartTRAK Life Sciences News and Analysis Blog in the Orthopedics, Wound, and Neuro Therapies Market Segments
.png)
Perfuze CEO Wayne Allen discusses the company, its novel technology and how the company plans to capture...
Dr. Marc Russo discusses his research on ultra-low frequency SCS and its potential to treat nociceptive ...
SmartTRAK is attending the upcoming North American Neuromodulation Society meeting (NANS) in Orlando, Fl...
Carsten Schroeder, president and CEO of Terumo Neuro, discusses the company’s plans to capture share and...
In 2024, SmartTRAK continued to empower you to Be The Expert in the MedTech industry. As your trusted re...
Q’Apel Medical CEO Jodie Fam discusses the company, strategies for growth and Q’Apel’s approach to innov...
SmartTRAK reports on the latest research and innovation in neurointervention from ESMINT 2024. The Europ...
SmartTRAK reports the latest research and innovation in interventional pain management from ASPN 2024. I...
Amaza Reitmeier, Medtronic’s VP and GM of Brain Modulation, discusses the company’s recent FDA approvals...
SmartTRAK's Anne Staylor, VP & GM Neuro Therapies, will be attending ESMINT 2024 SmartTRAK is excite...
Login